No difference in adherence to paroxetine between depressed patients with early remission and those with late remission based on monitoring of plasma paroxetine concentrations-Reference-Cited by-同舟云学术

No difference in adherence to paroxetine between depressed patients with early remission and those with late remission based on monitoring of plasma paroxetine concentrations

Published:2010-08-19 Issue:6 Volume:25 Page:487-490
ISSN:0885-6222
Container-title:Human Psychopharmacology: Clinical and Experimental
language:en
Short-container-title:Hum. Psychopharmacol. Clin. Exp.

Author:

Yoshimura Reiji,Umene-Nakano Wakako,Ueda Nobuhisa,Ikenouchi-Sugita Atsuko,Hori Hikaru,Katsuki Asuka,Hayashi Kenji,Miyamoto Kyoko,Kodama Yuki,Nakamura Jun

Publisher

Wiley

Subject

Pharmacology (medical),Psychiatry and Mental health,Neurology (clinical),Neurology

Reference19 articles.

1. An open-label series using loratadine for the treatment of sexual dysfunction associated with selective serotonin reuptake inhibitors;Aukst-Margetic;Prog Neuropsychopharmacol Biol Psychiatry,2005

2. Compliance with pharmacotherapy in mood disorders;Basco;Psychiatr Ann,1995

3. The association between concurrent psychotropic medications and self-reported adherence with taking a mood stabilizer in bipolar disorder;Bauer;Hum Psychopharmacol,2010

4. Enhancing medication adherence in patients with bipolar disorder;Berk;Hum Psychopharmacol,2010

5. Methods for evaluating patient adherence to antidepressant therapy: a real-world comparison of adherence and economic outcomes;Cantrell;Med Care,2006

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Plasma levels of paroxetine are not associated with the increase of serum levels of brain-derived neurotrophic factor in major depression;Clinical Neuropsychopharmacology and Therapeutics;2020-07-31

2. Clinical features and drug induced side effects in early versus late antidepressant responders;Journal of Psychiatric Research;2013-10

3. Determination of paroxetine in serum treated with simple pretreatment by pre-column high-performance liquid chromatography using 4-(5,6-dimethoxy-2-phthalimidinyl)-2-methoxyphenylsulfonyl chloride as a fluorescent labeling reagent;Biomedical Chromatography;2013-01-14